Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma
4 Strategies to Reduce Oncology Nurse Burnout, Stop ‘Silent Quitting’
Relapsed/Refractory Follicular Lymphoma May Respond to Loncastuximab Tesirine Plus Rituximab
Cilta-cel Demonstrates 99.4% ORR in Lenalidomide-Refractory Myeloma